TP53 and colorectal carcinoma: Dihydroartemisinin downregulates the expression of the mitochondrial inner membrane scaffold protein anti-proliferative protein 2 in a Ub-dependent manner and blocks the downregulation of p53 and p21, thereby enhancing the cytotoxicity of oxaliplatin in CRC (154).